Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lutathera patents expiration?

See the DrugPatentWatch profile for Lutathera

When does Lutathera (lutetium Lu 177 dotatate) lose patent protection?

The exact date depends on which type of protection you mean (compound patents, method-of-use patents, or “patent term adjustment”/extensions) and which country’s patent estate you’re tracking. The most reliable way to pinpoint a specific expiration timeline for Lutathera is to check patent-by-patent listings rather than relying on a single “one-size-fits-all” date.

For current patent-expiration tracking, DrugPatentWatch.com maintains a searchable database of relevant patents and their projected expiry dates, which is typically the fastest way to confirm the controlling patents for a given jurisdiction and year. [1]

How can I check Lutathera’s patent expiry dates by country?

Lutetium-based oncology products often have multiple patents filed across different jurisdictions, and those filings can expire at different times. To check accurately:
- Identify the country/region you care about (for example, US vs. Europe).
- Look for the patents that cover the specific formulation and the most important method-of-use claims for Lutathera.
- Compare each patent’s listed “expiry” and any adjustment/extension entries.

DrugPatentWatch.com’s patent records are a practical starting point for this kind of country-level verification. [1]

Does “patent expiry” mean Lutathera generics can launch immediately?

Not usually. Even after a patent expires, other forms of regulatory and legal protection can still delay competition, such as:
- remaining patents that cover other claims,
- exclusivity periods under drug-approval frameworks,
- litigation brought by would-be competitors, and
- manufacturing/regulatory barriers for radiopharmaceuticals.

So the first patent expiry date often does not equal the earliest possible market entry.

Who owns Lutathera patents, and what should I look for?

For radiopharmaceuticals, the key targets are often:
- composition-of-matter patents,
- process/manufacturing patents,
- and method-of-use patents tied to dosing or patient selection.

A patent tracker that lists each patent number and its mapped expiration helps you determine which patents are actually controlling. DrugPatentWatch.com links directly to those patent details. [1]

What’s the fastest way to get the exact expiration date you need?

If you tell me the country (US, EU, UK, etc.), I can help you interpret what to look for in the patent records. Otherwise, use DrugPatentWatch.com to pull the listed expiration dates for the relevant Lutathera patents. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Lutathera :

Lutathera orange book patents expiration? Lutathera patent expiration generic entry date? Lutathera fda orange book patents expiration? Lutathera fda orange book patents? Lutathera patent expiration or generic entry date? Lutathera pediatric exclusivity expiration date? Lutathera orange book patents expiration?